China Launches Bold Leptonic Breakthrough, New Brain Tissue Map Transforms Neurodegeneration, Pace Me Fails Against Standard Care, Smartwatch Signals Opioid Risk, and more...
Feb 03, 2026•11 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
(0:10): China Launches Ambitious MACE Experiment to Break New Ground in Leptonic Physics
(2:14): New Study Maps Living Brain Tissue, Revolutionizing Alzheimer's and Parkinson's Research
(4:36): Digital Platform 'Pace Me' Fails to Outperform Standard Care in Long COVID Trial, Yet Shows Promise
(6:58): Smartwatch Study Aims to Curb Opioid Misuse by Monitoring Heart Rate Variability
(8:50): EPA's New Policy Devalues Human Life, Threatens Decades of Public Health Progress
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: STAT
(2:14): New Study Maps Living Brain Tissue, Revolutionizing Alzheimer's and Parkinson's Research
(4:36): Digital Platform 'Pace Me' Fails to Outperform Standard Care in Long COVID Trial, Yet Shows Promise
(6:58): Smartwatch Study Aims to Curb Opioid Misuse by Monitoring Heart Rate Variability
(8:50): EPA's New Policy Devalues Human Life, Threatens Decades of Public Health Progress
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: STAT
For the best experience, listen in Metacast app for iOS or Android